Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
Collegium Pharmaceutical Inc. (COLL) is trading at $34.59 as of 2026-04-20, posting a 0.52% gain on the day amid muted broad market action for mid-cap healthcare stocks. This analysis breaks down key technical levels, recent market context for the specialty pharmaceutical name, and potential scenarios for upcoming price action, with no investment recommendations included. Key observations include a tight recent consolidation range between well-defined support and resistance levels, neutral short
Collegium (COLL) Stock Bollinger Bands (Hovering) 2026-04-20 - IPO Watch
COLL - Stock Analysis
4278 Comments
1188 Likes
1
Celsa
Loyal User
2 hours ago
Despite minor pullbacks, the overall market remains resilient with positive underlying trends.
π 252
Reply
2
Kaevon
Community Member
5 hours ago
Comprehensive US stock balance sheet stress testing and liquidity analysis for downside risk assessment. We model different scenarios to understand how companies would perform under adverse conditions.
π 64
Reply
3
Adalind
Influential Reader
1 day ago
Investors are weighing earnings reports against broader economic data.
π 87
Reply
4
Yvenson
Engaged Reader
1 day ago
This feels like a loop.
π 213
Reply
5
Kristelle
Active Reader
2 days ago
If only I had read this earlier. π
π 205
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.